Screener

Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year

Name: Collegium Pharmaceutical, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Collegium Pharmaceutical, Inc.·Products & Services·5 segments·Rolls up to Lease Liability Payments - Remainder of Fiscal Year

Breakdown

Segment	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Jornay PM	—	$20.96M	$62.87M	$41.92M	$20.96M	—	$62.87M	$41.92M
Belbuca	$37.7M	$18.85M	$56.54M	$37.69M	$18.85M	—	$56.54M	$37.7M
Azstarys	—	—	—	—	—	—	—	$27.28M
Symproic	$3.64M	$1.82M	$5.47M	$3.64M	$1.82M	—	$5.46M	$3.64M
Symproic and other	—	—	—	—	—	$7.29M	—	—
Total	—	—	—	—	—	—	—	—

Segments

Jornay PMView metric

BelbucaView metric

SymproicView metric

Symproic and otherView metric

AzstarysView metric